Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
|ClinicalTrials.gov Identifier: NCT00499785|
Recruitment Status : Completed
First Posted : July 11, 2007
Last Update Posted : May 30, 2017
RATIONALE: Learning about physical ability and mental function over time in older patients with acute myeloid leukemia may help doctors learn about the long-term effects of treatment and plan the best treatment.
PURPOSE: This clinical trial is assessing physical and mental status in older patients with newly diagnosed acute myeloid leukemia.
|Condition or disease|
|Cognitive/Functional Effects Depression Leukemia|
- Test the feasibility of pre-treatment, bedside assessment of functional and cognitive status in older adults with newly diagnosed acute myeloid leukemia (AML).
- Obtain preliminary data regarding the predictive value of pre-treatment, bedside assessment of functional and cognitive status on overall survival, length of hospitalization and early death.
OUTLINE: This is a prospective study.
At baseline, patients complete questionnaires including the Vulnerable Elders Survey (functional status), the Mini-Mental Status Exam (cognition), and the Center for Epidemiologic Studies-Depression. Patients also undergo physical function testing via the Short Physical Performance Battery and hand grip strength. Further information parameters are obtained by periodic medical chart reviews.
Patients are followed every 3 months for up to 2 years.
|Study Type :||Observational|
|Actual Enrollment :||11 participants|
|Official Title:||Inpatient Functional and Cognitive Assessment in Older Adults With Acute Myelogenous Leukemia|
|Study Start Date :||June 2007|
|Primary Completion Date :||January 2009|
|Study Completion Date :||January 2012|
|patients admitted with acute leukemia|
- feasibility of administering a functional assessment in clinical situation [ Time Frame: 72 hours of admission ]Assessment of physical and cognitive function via a set of physical and congnitive tests
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00499785
|United States, North Carolina|
|Wake Forest University Comprehensive Cancer Center|
|Winston-Salem, North Carolina, United States, 27157-1096|
|Principal Investigator:||Heidi D. Klepin, MD||Wake Forest University Health Sciences|
|Principal Investigator:||Bayard L. Powell, MD||Wake Forest University Health Sciences|